Ira T. Lott

12.3k total citations · 2 hit papers
148 papers, 8.0k citations indexed

About

Ira T. Lott is a scholar working on Public Health, Environmental and Occupational Health, Psychiatry and Mental health and Physiology. According to data from OpenAlex, Ira T. Lott has authored 148 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Public Health, Environmental and Occupational Health, 46 papers in Psychiatry and Mental health and 43 papers in Physiology. Recurrent topics in Ira T. Lott's work include Down syndrome and intellectual disability research (72 papers), Alzheimer's disease research and treatments (37 papers) and Dementia and Cognitive Impairment Research (36 papers). Ira T. Lott is often cited by papers focused on Down syndrome and intellectual disability research (72 papers), Alzheimer's disease research and treatments (37 papers) and Dementia and Cognitive Impairment Research (36 papers). Ira T. Lott collaborates with scholars based in United States, Spain and United Kingdom. Ira T. Lott's co-authors include Elizabeth Head, Mara Dierssen, Eric Doran, Carl W. Cotman, Paul M. Fernhoff, Paul J. Benke, Narsingh D. Agnish, Richard M. Hoar, Cynthia J. Curry and Edward J. Lammer and has published in prestigious journals such as Science, New England Journal of Medicine and Journal of Neuroscience.

In The Last Decade

Ira T. Lott

144 papers receiving 7.6k citations

Hit Papers

Retinoic Acid Embryopathy 1985 2026 1998 2012 1985 2019 400 800 1.2k

Peers

Ira T. Lott
Stephen R. Plymate United States
Alvin M. Matsumoto United States
Michael S. Rafii United States
Riccardo E. Marioni United Kingdom
Wayne Silverman United States
S. Mitchell Harman United States
Eef Hogervorst United Kingdom
Stephen R. Plymate United States
Ira T. Lott
Citations per year, relative to Ira T. Lott Ira T. Lott (= 1×) peers Stephen R. Plymate

Countries citing papers authored by Ira T. Lott

Since Specialization
Citations

This map shows the geographic impact of Ira T. Lott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ira T. Lott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ira T. Lott more than expected).

Fields of papers citing papers by Ira T. Lott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ira T. Lott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ira T. Lott. The network helps show where Ira T. Lott may publish in the future.

Co-authorship network of co-authors of Ira T. Lott

This figure shows the co-authorship network connecting the top 25 collaborators of Ira T. Lott. A scholar is included among the top collaborators of Ira T. Lott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ira T. Lott. Ira T. Lott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lott, Ira T., et al.. (2025). Cognitive and Behavioural Associations of Visual and Hearing Impairments Across the Lifespan in People With Down Syndrome, a Scoping Review. Journal of Intellectual Disability Research. 69(9). 753–780. 1 indexed citations
2.
Doran, Eric, et al.. (2024). Comparing research attitudes in Down syndrome and non‐Down syndrome research decision‐makers. Alzheimer s & Dementia Translational Research & Clinical Interventions. 10(3). e12478–e12478.
3.
Boerwinkle, Anna H., Julie K. Wisch, Benjamin L. Handen, et al.. (2024). The mediating role of plasma glial fibrillary acidic protein in amyloid and tau pathology in Down's syndrome. Alzheimer s & Dementia. 21(1). e14359–e14359. 5 indexed citations
4.
Hartley, Sigan L., Annie Cohen, Beau M. Ances, et al.. (2022). Impact of the COVID-19 pandemic on daily life, mood, and behavior of adults with Down syndrome. Disability and health journal. 15(3). 101278–101278. 11 indexed citations
5.
Lott, Ira T., Katharine A. Kirby, Eric Doran, & Joshua D. Grill. (2022). Research attitudes in families of individuals with Down syndrome: importance for clinical trials. Alzheimer s Research & Therapy. 14(1). 176–176. 11 indexed citations
6.
Hendrix, James A., Brian Chicoine, Florence Lai, et al.. (2021). Development of a symptom menu to facilitate Goal Attainment Scaling in adults with Down syndrome-associated Alzheimer’s disease: a qualitative study to identify meaningful symptoms. Journal of Patient-Reported Outcomes. 5(1). 5–5. 4 indexed citations
7.
8.
Miranda, André Miguel, Mathieu Herman, Rong Cheng, et al.. (2018). Excess Synaptojanin 1 Contributes to Place Cell Dysfunction and Memory Deficits in the Aging Hippocampus in Three Types of Alzheimer’s Disease. Cell Reports. 23(10). 2967–2975. 38 indexed citations
9.
Head, Elizabeth, Michael Phelan, Eric Doran, et al.. (2017). Cerebrovascular pathology in Down syndrome and Alzheimer disease. Acta Neuropathologica Communications. 5(1). 93–93. 59 indexed citations
10.
Sánchez‐Mut, José V., Ester Aso, Nicolas Panayotis, et al.. (2013). DNA methylation map of mouse and human brain identifies target genes in Alzheimer’s disease. Brain. 136(10). 3018–3027. 113 indexed citations
11.
Cenini, Giovanna, Amy L.S. Dowling, Tina L. Beckett, et al.. (2011). Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1822(2). 130–138. 101 indexed citations
12.
Lott, Ira T. & Mara Dierssen. (2010). Cognitive deficits and associated neurological complications in individuals with Down's syndrome. The Lancet Neurology. 9(6). 623–633. 332 indexed citations
13.
Zigman, Warren B. & Ira T. Lott. (2007). Alzheimer's disease in Down syndrome: Neurobiology and risk. Mental Retardation and Developmental Disabilities Research Reviews. 13(3). 237–246. 202 indexed citations
14.
Lott, Ira T., Elizabeth Head, Eric Doran, & Jorge Busciglio. (2006). Beta-Amyloid, Oxidative Stress and Down Syndrome. Current Alzheimer Research. 3(5). 521–528. 87 indexed citations
15.
Head, Elizabeth & Ira T. Lott. (2004). Down syndrome and beta-amyloid deposition. Current Opinion in Neurology. 17(2). 95–100. 87 indexed citations
16.
Lott, Ira T. & Elizabeth Head. (2001). Down syndrome and Alzheimer's disease: A link between development and aging. Mental Retardation and Developmental Disabilities Research Reviews. 7(3). 172–178. 121 indexed citations
17.
Azizeh, Bassem Y., Elizabeth Head, Reidun Torp, et al.. (2000). Molecular Dating of Senile Plaques in the Brains of Individuals with Down Syndrome and in Aged Dogs. Experimental Neurology. 163(1). 111–122. 47 indexed citations
18.
Lott, Ira T. & Ernest E. McCoy. (1992). Down syndrome : advances in medical care. 59 indexed citations
19.
Lott, Ira T., David L. McPherson, Barbara H. Towne, David Johnson, & Arnold Starr. (1990). Long-term neurophysiologic outcome after neonatal extracorporeal membrane oxygenation. The Journal of Pediatrics. 116(3). 343–349. 44 indexed citations
20.
Lott, Ira T., John T. Dulaney, Aubrey Milunsky, D. Hoefnagel, & Hugo W. Moser. (1976). Apparent biochemical homozygosity in two obligatory heterozygotes for metachromatic leukodystrophy. The Journal of Pediatrics. 89(3). 438–440. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026